Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Neisseria gonorrhoeae bacteria

A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Project to Sequence 20K Dog and Cat Genomes

Dog's nose

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Breast tumor microenvironment

Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Nasal Spray Vaccines Get CEPI, NIH Funding

Nasal spray

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

NIH Funds Decentralized Rare Disease Data Network

Blockchain

A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network

Exec. Order Aims to Boost U.S. Biotech, Manufacturing

White House, Lafayette Square

An executive order issued by President Joe Biden yesterday seeks to make biotechnology and biomanufacturing a centerpiece of the American economy. . . . → Read More: Exec. Order Aims to Boost U.S. Biotech, Manufacturing

Trial to Test Smart Watch to Guide Blood Thinners

Operating a smart watch

A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat. . . . → Read More: Trial to Test Smart Watch to Guide Blood Thinners

Women’s Health Companies Partner on New Contraceptive

Women silhouettes

Two companies working in women’s reproductive health are developing a new non-hormonal contraceptive that works in cervical mucous membranes. . . . → Read More: Women’s Health Companies Partner on New Contraceptive

Small Biz Grant Funds Non-Viral Gene Editing Delivery

Small bubbles

National Institutes of Health is financing a delivery method for gene-editing therapies to blood-forming stem cells with natural lipid bubbles instead of viruses. . . . → Read More: Small Biz Grant Funds Non-Viral Gene Editing Delivery

NIH Funding Engineered Phage Screening Device

National Institutes of Health is funding initial development of a microfluidic device that tests engineered viruses for their ability to kill disease-causing bacteria. . . . → Read More: NIH Funding Engineered Phage Screening Device